Humana (NYSE:HUM) Stock Price Up 2%

Humana Inc. (NYSE:HUM) rose 2% on Tuesday . The company traded as high as $330.00 and last traded at $320.84. Approximately 742,737 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 2,002,590 shares. The stock had previously closed at $314.64.

Analysts Set New Price Targets

HUM has been the subject of a number of analyst reports. The Goldman Sachs Group decreased their price target on Humana from $450.00 to $385.00 and set a “buy” rating for the company in a report on Wednesday, April 3rd. Oppenheimer restated an “outperform” rating and issued a $630.00 price target on shares of Humana in a report on Wednesday, January 17th. Stephens decreased their price target on Humana from $550.00 to $430.00 and set an “overweight” rating for the company in a report on Friday, January 26th. Truist Financial reiterated a “hold” rating and set a $550.00 target price on shares of Humana in a research note on Friday, January 19th. Finally, TheStreet cut Humana from a “b” rating to a “c+” rating in a research note on Monday, January 8th. Eleven investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $465.42.

Humana Price Performance

The company has a debt-to-equity ratio of 0.63, a current ratio of 1.59 and a quick ratio of 1.59. The company has a 50-day simple moving average of $344.41 and a two-hundred day simple moving average of $425.71. The stock has a market capitalization of $39.03 billion, a price-to-earnings ratio of 16.32, a price-to-earnings-growth ratio of 1.86 and a beta of 0.45.

Humana (NYSE:HUM) last issued its earnings results on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share for the quarter, missing the consensus estimate of $0.76 by ($0.87). Humana had a return on equity of 19.44% and a net margin of 2.34%. The company had revenue of $26.46 billion during the quarter, compared to analyst estimates of $25.47 billion. During the same period in the prior year, the business earned $1.62 earnings per share. Humana’s quarterly revenue was up 17.9% on a year-over-year basis. On average, equities research analysts predict that Humana Inc. will post 16.06 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.09%. Humana’s payout ratio is 17.86%.

Insider Transactions at Humana

In other Humana news, Director Jorge S. Mesquita purchased 545 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was bought at an average price of $367.09 per share, with a total value of $200,064.05. Following the completion of the purchase, the director now owns 2,578 shares in the company, valued at approximately $946,358.02. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 0.32% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Cibc World Market Inc. boosted its stake in Humana by 4.0% during the first quarter. Cibc World Market Inc. now owns 5,709 shares of the insurance provider’s stock valued at $2,484,000 after buying an additional 217 shares in the last quarter. Blair William & Co. IL boosted its stake in Humana by 0.6% during the first quarter. Blair William & Co. IL now owns 5,660 shares of the insurance provider’s stock valued at $2,463,000 after buying an additional 32 shares in the last quarter. Cetera Investment Advisers boosted its stake in Humana by 0.5% during the first quarter. Cetera Investment Advisers now owns 4,906 shares of the insurance provider’s stock valued at $2,135,000 after buying an additional 26 shares in the last quarter. Sequoia Financial Advisors LLC boosted its stake in Humana by 19.0% during the first quarter. Sequoia Financial Advisors LLC now owns 615 shares of the insurance provider’s stock valued at $268,000 after buying an additional 98 shares in the last quarter. Finally, Candriam Luxembourg S.C.A. boosted its stake in Humana by 25.0% during the first quarter. Candriam Luxembourg S.C.A. now owns 29,809 shares of the insurance provider’s stock valued at $12,971,000 after buying an additional 5,964 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.